Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

HDL-Atherosclerosis Treatment Study (HATS)

NCT00000553 is registered in ClinicalTrials.gov with University of Washington as lead sponsor.

NCT NCT00000553
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00000553 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
HDL-Atherosclerosis Treatment Study (HATS)
Lead sponsor
University of Washington
Phase
Phase 3
Overall status
Completed
Start date
September 30, 1994
Completion date
February 28, 2001
Enrollment
Not reported
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

cardiovascular diseases, coronary disease, heart diseases, myocardial ischemia